Skip to content

Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota on Constipation of Depressed Patients

Effect of Fermented Milk Containing Lactobacillus Casei Strain Shirota on Constipation of Depressed Patients

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025972
Enrollment
Unknown
Registered
2019-09-16
Start date
2019-09-04
Completion date
Unknown
Last updated
2019-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation of Depressed Patients

Interventions

experimental group:Yakult
Placebo group:Placebo

Sponsors

China Agricultural University.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. People between the age of 18-60 years at the beginning of the study. 2. Normal body mass index: 18.5-29.9. 3. Mild to moderate major depression diagnosed by psychiatrists according to the diagnostic criteria for depressive episodes in DSM-5 (American Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition)). 4. Diagnosis of constipationaccording to the diagnosis of doctors from the Hospital of China Agricultural University. (Diagnosis of constipation is normally performed according to the Rome IV Criteria. Rome IV criteria is as below: (1) Must include two or more of the following: a. Straining during more than one-fourth (25%) of defecations; b. Lumpy or hard stools (Bristol stool form scale 1 or 2) more than one-fourth (25%) of defecations; c. Sensation of incomplete evacuation more than one-fourth (25%) of defecations; d. Sensation of anorectal obstruction/blockage more than one-fourth (25%) of defecations; e. Manual manoeuvres to facilitate more than one-fourth (25%) of defecations (such as digital evacuation, or support of the pelvic floor); f. Fewer than 3 spontaneous bowel movements per week. (2) Loose stools are rarely present without the use of laxatives. (3) Insufficient criteria for irritable bowel syndrome. Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis) 5. Hamilton Rating Scale for Depression (HRSD) 17 items >= 8 scores. 6. Agreed to drink study product during the study period. 7. Agreed to sign written informed consent.

Exclusion criteria

Exclusion criteria: 1. Use of systemic antibiotics or antimycotics medication in the 30 days prior to the study. 2. Use of antidiarrheal or laxative medication in the 30 days prior to the study. 3. Investigator's uncertainty about the willingness or ability of subject to comply with the protocol requirements. 4. Persons with a milk protein allergy, lactose intolerance, or constipation of organic or neurological origin. 5. Pregnant or breastfeeding women. 6. Start using antidepressants within two weeks. 7. Participation in any other studies within two months prior to entry into the study.

Design outcomes

Primary

MeasureTime frame
severity of constipation;

Secondary

MeasureTime frame
depressive symptoms;intestinal microbiota;mmune factors (IL-6, IL-1ß, TNF-a);serum cortisol;serum BDNF;

Countries

China

Contacts

Public ContactRen Fazheng

China Agricultural University

renfazheng@263.net+86 010-62736344

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026